Better Dividend: Pfizer vs. Bristol-Myers Squibb
Picking great dividend stocks isn't about just finding the highest-paying yields. The best stocks offer great dividends along with a steady outlook and a secure financial base. Big Pharma's traditionally been home to several strong dividend stocks, with some offering up chart-topping yields.
Just which of Big Pharma's stocks offers your portfolio the best dividend? Motley Fool contributor Dan Carroll below compares two of the industry's biggest names, Pfizer and Bristol-Myers Squibb and shows you which of these two titans is the better pick for long-term investors searching for a great dividend.
One of the best parts of owning big pharma stocks is their attractive dividends, but smart investors know the importance of diversifying -- seeking high-yielding stocks from multiple industries. The Motley Fool's special free report "Secure Your Future With 9 Rock-Solid Dividend Stocks" outlines the Fool's favorite dependable dividend-paying stocks across all sectors. Grab your free copy by clicking here.
The article Better Dividend: Pfizer vs. Bristol-Myers Squibb originally appeared on Fool.com.
Fool contributor Dan Carroll and The Motley Fool have no position in any of the stocks mentioned. Try any of our Foolish newsletter services free for 30 days. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.
Copyright © 1995 - 2013 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.
